Octapharma Usa, Inc.

Octapharma Usa, Inc. company information, Employees & Contact Information

Octapharma USA, headquartered in Paramus, N.J., is a subsidiary of Octapharma AG, a global human protein products powerhouse, dedicated to the research and manufacture of human proteins. We have been committed to patient care and medical innovation for 40 years. Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. Since being established in 1983, Octapharma is a global healthcare company headquartered in Lachen, Switzerland. Our products are available in 118 countries and reach hundreds of thousands of patients every year.

Company Details

Employees
91
Founded
-
Address
117 W Century Rd, Paramus,new Jersey 07652,united States
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
HQ
Paramus, New Jersey
Looking for a particular Octapharma Usa, Inc. employee's phone or email?

Octapharma Usa, Inc. Questions

News

Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development - PR Newswire

Octapharma USA Appoints Biopharma Industry Veteran Kelly Hearn Vice President of Commercial Marketing & Development PR Newswire

Octapharma USA to present clinical overview of dermatomyositis during The Myositis Association’s Annual Conference - EurekAlert!

Octapharma USA to present clinical overview of dermatomyositis during The Myositis Association’s Annual Conference EurekAlert!

FDA Extends Expiration Date of Immunoglobulin Product Cutaquig - Medical Professionals Reference

FDA Extends Expiration Date of Immunoglobulin Product Cutaquig Medical Professionals Reference

FDA Approvals Strengthen Octapharma USA Pediatric Critical Care Product Portfolio - Business Wire

FDA Approvals Strengthen Octapharma USA Pediatric Critical Care Product Portfolio Business Wire

Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures - The AI Journal

Octapharma Announces Availability of Balfaxar® For Warfarin Reversal in Urgent Surgery & Invasive Procedures The AI Journal

Octapharma USA: FDA Grants Expanded Approval to wilate® as the First VWF Concentrate for Prophylaxis in All Types of VWD - PR Newswire

Octapharma USA: FDA Grants Expanded Approval to wilate® as the First VWF Concentrate for Prophylaxis in All Types of VWD PR Newswire

10% Receives 7 Years of Market Exclusivity for Adult Dermatomyositis - Business Wire

10% Receives 7 Years of Market Exclusivity for Adult Dermatomyositis Business Wire

Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All Types of VWD - PR Newswire

Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®, the First VWF Concentrate for Prophylaxis in All Types of VWD PR Newswire

Octapharma USA Announces Medicare Part B Approval of cutaquig® 16.5% for Adult PI Patients - Business Wire

Octapharma USA Announces Medicare Part B Approval of cutaquig® 16.5% for Adult PI Patients Business Wire

Octapharma USA Requests FDA Approval for wilate® VWD Prophylaxis Supplement - PR Newswire

Octapharma USA Requests FDA Approval for wilate® VWD Prophylaxis Supplement PR Newswire

FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis - Business Wire

FDA Approves Octapharma’s Octagam® 10% for Adult Dermatomyositis Business Wire

Octapharma USA Sponsored Bombardier Blood Presented by Denver Mountain Climber During Special Hometown Screening - PR Newswire

Octapharma USA Sponsored Bombardier Blood Presented by Denver Mountain Climber During Special Hometown Screening PR Newswire

Octapharma USA Sponsors Educational National Conference for Type 3 Von Willebrand Disease Patients - PR Newswire

Octapharma USA Sponsors Educational National Conference for Type 3 Von Willebrand Disease Patients PR Newswire

Octapharma's Prothrombin Complex Concentrate, Balfaxar®, Receives FDA Approval For Warfarin Reversal in Urgent Surgery & Invasive Procedures - PR Newswire

Octapharma's Prothrombin Complex Concentrate, Balfaxar®, Receives FDA Approval For Warfarin Reversal in Urgent Surgery & Invasive Procedures PR Newswire

Top Octapharma Usa, Inc. Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant